Yongin-si, Gyeonggi-do,, Korea
GNTP is a biopharmaceutical company established in April 1998 with the aim of developing innovative medicines and technologies for the treatment of neurological disorders such as stroke and Alzheimer’s disease.
While new drug development for brain diseases has traditionally targeted an individual identified disease mechanism, GNT has focused its efforts on "multi-targeting" multiple concurrent disease mechanisms, an approach proven effective and sometimes even necessary in other fields such as cancer.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for GNT Pharma on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
